Figure 8 Investment Strategies’s GSK GSK Stock Holding History

Figure 8 Investment Strategies’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Buy	38,686 +18,380	+91%	+$972K	1.71%	21
2026 Q1	$1.12M	Buy	20,306 +1,607	+9%	+$87.1K	1.09%	40
2025 Q4	$917K	Sell	18,699 -28	-0.1%	-$1.31K	0.82%	45
2025 Q3	$808K	Buy	18,727 +2,860	+18%	+$112K	0.72%	45
2025 Q2	$609K	Sell	15,867 -1,079	-6%	-$41.2K	0.6%	50
2025 Q1	$656K	Buy	16,946 +2,490	+17%	+$91.2K	0.69%	42
2024 Q4	$489K	Buy	+14,456	New	+$520K	0.48%	43

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Figure 8 Investment Strategies's GSK Position: Q2 2026 in Review

Figure 8 Investment Strategies increased its GSK (GSK) stake by 91% in Q2 2026, buying an estimated $972K and bringing the position to 38,686 shares worth $2.03M. The position accounts for 1.71% of the portfolio, ranked #21.

Figure 8 Investment Strategies first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Figure 8 Investment Strategies held 38,686 shares of GSK worth $2.03M as of Q2 2026.
Figure 8 Investment Strategies bought 18,380 GSK shares in Q2 2026, an estimated $972K.
GSK made up 1.71% of Figure 8 Investment Strategies's portfolio in Q2 2026, its #21 holding.
Figure 8 Investment Strategies first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Figure 8 Investment Strategies's 13F filing for Q2 2026, filed 7 Aug 2026.